Globus Medical, Inc.
GMED
$85.90
-$0.04-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.28% | 64.72% | 430.44% | 129.50% | 538.68% |
| Total Depreciation and Amortization | -1.55% | 6.44% | 2.64% | 6.05% | 10.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.40% | 36.62% | -32.21% | 15.98% | -283.77% |
| Change in Net Operating Assets | 2.76% | -392.87% | -178.89% | -95.01% | 51.58% |
| Cash from Operations | 169.36% | 14.14% | 18.18% | 22.61% | 43.51% |
| Capital Expenditure | 28.77% | -9.73% | -169.98% | 14.62% | -67.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 99.41% | 1.82% | -- | 100.00% | -5,068.77% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -180.09% | 25.01% | -247.78% | -100.00% |
| Cash from Investing | 56.86% | -239.04% | -7.04% | -406.73% | -2,782.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 133.57% | 131.32% | -9.42% | -52.87% | -67.01% |
| Repurchase of Common Stock | -430.28% | 98.22% | -4,740.58% | -4,631.55% | -1,131.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -136.44% | -11.16% | 49.72% | -9.54% | -15.32% |
| Cash from Financing | -439.34% | 102.86% | -77.88% | -263.62% | -386.34% |
| Foreign Exchange rate Adjustments | -95.84% | -187.40% | 194.30% | -87.43% | 280.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.05% | 110.77% | -4.51% | -32.97% | -511.31% |